Document is current
Any future updates will be listed below
-
Authors
Meyer, Björn
Riepenhausen, Antje
Betz, Linda T.
Jauch-Chara, Kamila
Reshetnik, Alexander
- License Information
-
More Information
Article History
Received: 28 May 2024
Accepted: 21 March 2025
First Online: 4 April 2025
Declarations
:
: This study was approved by the ethics committee of the medical faculty at the Christian-Albrechts-Universität zu Kiel (D 560/21). Participants provided informed consent to participate.
: Not applicable.
: BM, A Riepenhausen and LB are employees of GAIA, the developer, owner, and distributor of liebria. A Reshetnik is a clinical advisor to GAIA and received consultancy fees.
